Navigation Links
Biodel Reports Positive Top-Line Results from Study of Experimental Ultra-Rapid-Acting Insulin Formulations
Date:4/15/2012

in the case of BIOD-123 and BIOD-125 and insulin lispro in the case of Humalog®.  The clinical trial was powered to measure differences in time to half maximal insulin concentrations.  Pharmacodynamic measurements were assessed using the euglycemic clamp method.  Local injection site discomfort was measured with a 100 mm visual analog scale (VAS) and patient questionnaires. 

In the Phase 1 clinical trial, absorption rates of BIOD-123 and BIOD-125 were significantly faster than that of Humalog® as indicated by 64% and 54% reductions, respectively, in mean times to half maximal insulin concentrations (p<0.001 for both BIOD-123 and BIOD-125 compared to Humalog®).  In a previous clinical trial, the Linjeta™ formulation demonstrated a 61% reduction compared to Humalog®.  Peak metabolic effects were not significantly different between the three study drugs. 

All three were well tolerated, with injection site tolerability generally perceived by patients to be similar to that of their usual mealtime injections used at home.  As measured on a 100 mm visual analog scale in which 100 mm is defined as the worst possible injection discomfort, local toleration was not significantly different for BIOD-123 compared to Humalog® (BIOD-123 mean VAS 3.6 +/- 2.1 mm, Humalog® 1.8 +/- 1.1 mm, p=NS).  The VAS score for BIOD-125 was slightly higher as compared to Humalog® (mean VAS 6.8 +/- 2.9 mm, p<0.05).  However, this score was markedly improved relative to the Linjeta™ formulation, which had a mean VAS of 22.0 +/- 2.8 mm in a previous study. 

Dr. Alan Krasner, Biodel's chief medical officer, stated: "Biodel's previous Linjeta™ formulation demonstrated a desirable ultra-rapid absorption profile, but had challenges with respect to local injection site toleration.  The goal of our subsequent formulation development has been to maintain the ultr
'/>"/>

SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report
2. Biodel to Provide Update on Stabilized Glucagon Program at ROTH Conference Today
3. Federal Court Grants Request by BioDelivery Sciences for Stay of MonoSol Litigation
4. Biodel Inc. to Present at ROTH 24th Annual OC Growth Stock Conference on March 14th, 2012
5. US Patent Office Rejection of All Claims in Final Asserted MonoSol Patent Further Supports BioDelivery Sciences Position
6. BioDelivery Sciences and FDA Reach Agreement on BNX Development Plan
7. Biodel Inc. to Present at 30th Annual JPMorgan Healthcare Conference on January 12th, 2012
8. Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine
9. BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine
10. BioDelivery Sciences Announces Confirmation of Final Formulation of BEMA Buprenorphine/Naloxone Based on Positive BNX-102 Study
11. Biodel to Report Fourth Quarter Fiscal Year 2011 Financial Results on December 6, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... December 19, 2014 TODAY, AEGATE, ... the World announced the appointment of Peter Fox ... as Chief Channels and Partner Officer. Peter ... through to its acquisition by Oracle in 2011. ... Geneva and subsequently Convergys, a ...
(Date:12/19/2014)... , Dec. 19, 2014   Hospira, Inc. ... of injectable drugs and infusion technologies, today announced that ... Annual Healthcare Conference on Wednesday, Jan. 14, 2015, in ... scheduled to begin at 10:30 a.m. Pacific time on ... all interested parties through a live audiocast accessible via ...
(Date:12/19/2014)... WORTH, Texas , December 18, 2014 /PRNewswire/ ... a networked software application/module that is used to ... related images. RIS comprises a patient tracking and ... system. The integration of RIS with HIS and ... used for patient registration and patient scheduling, patient ...
Breaking Medicine Technology:Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3
... Aug. 23 Biopure Corporation,(Nasdaq: BPUR ) ... clinical,study protocol to the FDA for compassionate use ... States. The proposed open label,study would make Hemopure ... or potentially life threatening anemia on a compassionate ...
... Alfacell Corporation,(Nasdaq: ACEL ) today announced that ... (2007; Vol. 31, Issue 3: 663-669) reports that,ONCONASE(R) ... types and tumor cell lines. The observed antioxidant ... effect on cancer cells and,mechanistic synergism with other ...
Cached Medicine Technology:Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia 2Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia 3Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 2Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 3
(Date:12/22/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- U.S. and ... to caramel apples that has killed at least four ... Consumers should not eat any commercially produced, prepackaged caramel ... for Disease Control and Prevention said in a news ... 28 people had been infected with the outbreak strains ...
(Date:12/22/2014)... 2014 Physicians in China are most ... treatment of non-Hodgkin’s lymphoma (NHL), according to a new ... healthcare consulting firm. MabThera is the only biologic available ... common form of NHL. , According to Kantar Health’s ... incidence of NHL in China has been growing and ...
(Date:12/22/2014)... Colorado (PRWEB) December 22, 2014 Super ... Black Friday this year as the busiest day in ... other retailers, The Grass Station had a steady pre-Christmas ... holiday gifts, this past Saturday. , “I definitely intend ... 33-year-old Robert, a Denver resident who was enjoying The ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Only weeks ... southern and mid-western cities to have a battery manufacturer ... TalkLocal ( http://www.talklocal.com ) is launching in Henderson ... economy. , “A strong manufacturing sector is going ... founder Gurpreet Singh explained, “and TalkLocal works with small ...
(Date:12/22/2014)... In recognition of Veteran’s Day, Discount Labels ... a local organization that provides services to veterans and ... on a couple hundred acres in the hills of ... class fishing, hunting, hiking, horseback riding, 4-wheeling, skeet shooting, ... ago to support U.S. Service men and women, police ...
Breaking Medicine News(10 mins):Health News:CDC Warns of Listeria Danger From Caramel Apples 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:Customers at Colorado’s Grass Station Say They’re Enjoying the Experience of Legally Purchasing Marijuana this Year to Give as Christmas Presents to Friends and Family 2Health News:TalkLocal Launches in Henderson Weeks Following New Megafactory, New Jobs Announcement 2Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2
... Capital BlueCross announced today that it will cover an ... and those with individual coverage during the upcoming 2009-2010 flu ... to include this benefit. , , A ... October. Various clinical vaccine trials have begun, some under the ...
... NEW YORK, Sept. 16 Dr. Mark Hasten, chairman of the ... Kadish, M.D., as senior provost and chief operating officer for Touro ... http://www.flickr.com/photos/tourocollege/3923514965/ , , Touro is ... college was founded by Dr. Bernard Lander in 1970, originally as ...
... , FARMINGTON HILLS, Mich., Sept. ... stock and assets of GTL, Inc. dba as "Link to ... product and service offerings into CST to provide cost-effective personal ... and quality of life for older adults, the disabled and ...
... 20% of emergency room visits and 5% of ... first-line treatment option in patients with gastrointestinal bleeding, ... diagnostic and treatment method in patients with gastrointestinal ... incidence of rebleeding in patients with negative initial ...
... HEATHROW, Fla., Sept. 16 Cozmix, Inc., a sales ... beta release of SizeMix, the sales industry,s first point and ... forms a core component of Cozmix, SizeMix Process. , ... components necessary to complete a full internal review of a ...
... , BALTIMORE, Sept. 16 While most men ... likely unaware of other important statistics that could one day save ... and the National Football League (NFL) are teaming to encourage men ... of cancer death for American men. Men and their loved ones ...
Cached Medicine News:Health News:Capital BlueCross to Cover Administration Costs of H1N1 Vaccine for Fully-Insured Groups, Individuals This Flu Season 2Health News:Touro Appoints Alan Kadish, M.D., Senior Provost and Chief Operating Officer 2Health News:Touro Appoints Alan Kadish, M.D., Senior Provost and Chief Operating Officer 3Health News:Touro Appoints Alan Kadish, M.D., Senior Provost and Chief Operating Officer 4Health News:Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth, Personal Emergency Response and Medical Monitoring Systems 2Health News:Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth, Personal Emergency Response and Medical Monitoring Systems 3Health News:Sales Force Sizing and Resource Optimization Software Is the First of Its Kind to Enter the Market (Beta Release) 2Health News:Video: NFL Season Kicks Off With Campaign to 'Know Your Stats About Prostate Cancer' 2Health News:Video: NFL Season Kicks Off With Campaign to 'Know Your Stats About Prostate Cancer' 3Health News:Video: NFL Season Kicks Off With Campaign to 'Know Your Stats About Prostate Cancer' 4
Fine 3.0 mm platformed angled 60 degrees 10 mm from angle to tip. Serrated handle with dull finish....
Tennant straight tying forceps, 6.0 mm tying platforms, with pin, extra delicate smooth jaws....
Sinskey tying forceps, straight, fine, 7 mm tying platforms....
O'Gawa-Castroviejo tying forceps, straight shafts, 6 mm tying platforms, wide handle....
Medicine Products: